Douglas Testa

958 total citations
31 papers, 792 citations indexed

About

Douglas Testa is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Douglas Testa has authored 31 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Douglas Testa's work include Hepatitis C virus research (7 papers), Bacteriophages and microbial interactions (6 papers) and Virus-based gene therapy research (5 papers). Douglas Testa is often cited by papers focused on Hepatitis C virus research (7 papers), Bacteriophages and microbial interactions (6 papers) and Virus-based gene therapy research (5 papers). Douglas Testa collaborates with scholars based in United States, Canada and Switzerland. Douglas Testa's co-authors include A K Banerjee, Pranab K. Chanda, Nancy Lee, Mei‐June Liao, M J Liao, George R. Stark, Ewert Schulte‐Frohlinde, L. Leadbeater, Graham R. Foster and H. C. Thomas and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Douglas Testa

30 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Testa United States 15 327 251 193 164 141 31 792
Shinji Ohgimoto Japan 20 540 1.7× 287 1.1× 309 1.6× 127 0.8× 118 0.8× 29 1.0k
Delphine Sitterlin France 14 555 1.7× 573 2.3× 194 1.0× 163 1.0× 183 1.3× 20 1.1k
William Meinke United States 18 147 0.4× 362 1.4× 106 0.5× 197 1.2× 41 0.3× 31 809
Г. В. Кочнева Russia 16 176 0.5× 196 0.8× 122 0.6× 287 1.8× 73 0.5× 75 609
E M Scolnick United States 12 155 0.5× 337 1.3× 189 1.0× 396 2.4× 42 0.3× 13 772
R A Bhat United States 10 207 0.6× 248 1.0× 75 0.4× 141 0.9× 158 1.1× 10 536
H. Baumgarten Germany 9 636 1.9× 284 1.1× 202 1.0× 64 0.4× 391 2.8× 12 944
Pieter C. Van Breugel Netherlands 8 567 1.7× 561 2.2× 116 0.6× 97 0.6× 317 2.2× 9 1.0k
A Ishimoto Japan 15 269 0.8× 275 1.1× 385 2.0× 225 1.4× 43 0.3× 32 1.2k
Christine M. Livingston United States 12 741 2.3× 461 1.8× 185 1.0× 137 0.8× 354 2.5× 16 1.1k

Countries citing papers authored by Douglas Testa

Since Specialization
Citations

This map shows the geographic impact of Douglas Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Testa more than expected).

Fields of papers citing papers by Douglas Testa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Testa. The network helps show where Douglas Testa may publish in the future.

Co-authorship network of co-authors of Douglas Testa

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Testa. A scholar is included among the top collaborators of Douglas Testa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Testa. Douglas Testa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manzini, Paola, Osvaldo Giachino, Roberto Guaschino, et al.. (2007). Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica. 92(12). 1664–1670. 89 indexed citations
2.
Dı́az, Manuel O. & Douglas Testa. (1996). Type I interferon genes and proteins. Biotherapy. 8(3-4). 157–162. 5 indexed citations
3.
Hussain, Musaddeq, Dalip S. Gill, Mei‐June Liao, & Douglas Testa. (1996). Interferon-α8b the Only Variant of Interferon-α8 Identified in a Large Human Population. Journal of Interferon & Cytokine Research. 16(7). 523–529. 5 indexed citations
4.
Swindells, Susan, Colleen Kelly, Lisa Baca-Regen, et al.. (1996). Regulation and Characterization of the Interferon-α Present in Patients with Advanced Human Immunodeficiency Virus Type 1 Disease. Journal of Interferon & Cytokine Research. 16(2). 127–137. 16 indexed citations
5.
Foster, Graham R., Osiyallê Akanni Silva Rodrigues, Ewert Schulte‐Frohlinde, et al.. (1996). Different Relative Activities of Human Cell-Derived Interferon-α Subtypes: IFN-α8 Has Very High Antiviral Potency. Journal of Interferon & Cytokine Research. 16(12). 1027–1033. 106 indexed citations
6.
Lee, Nancy, R E Brissette, Musaddeq Hussain, et al.. (1995). Interferon-α 2 Variants in the Human Genome. Journal of Interferon & Cytokine Research. 15(4). 341–349. 14 indexed citations
7.
Sidhu, Maninder K., Abbas Rashidbaigi, Douglas Testa, & Mei‐June Liao. (1995). Competitor internal standards for quantitative detection of mycoplasma DNA. FEMS Microbiology Letters. 128(2). 207–211. 10 indexed citations
8.
Sidhu, Maninder K., Abbas Rashidbaigi, Mei‐June Liao, & Douglas Testa. (1995). Distinction between HIV-1 and HIV-2 nucleotide sequences by PCR and restriction enzyme analysis.. PubMed. 18(1). 20, 22, 24–20, 22, 24. 2 indexed citations
9.
Liao, Mei‐June, et al.. (1994). Interferon-α 2 Produced by Normal Human Leukocytes Is Predominantly Interferon-α 2b. Journal of Interferon Research. 14(6). 325–332. 16 indexed citations
10.
Liao, M J, N. Lee, Musaddeq Hussain, et al.. (1994). Distribution of Interferon-α 2 Genes in Humans. Journal of Interferon Research. 14(4). 183–185. 10 indexed citations
11.
Skillman, Donald R., et al.. (1993). Increased Efficacy of Human Natural Interferon α (IFN-αn3) Versus Human Recombinant IFN-α2 for Inhibition of HIV-1 Replication in Primary Human Monocytes. AIDS Research and Human Retroviruses. 9(11). 1115–1122. 15 indexed citations
12.
Testa, Douglas, et al.. (1992). Absence of Neutralizing Antibodies to Interferon in Condyloma Acuminata and Cancer Patients Treated with Natural Human Leukocyte Interferon. The Journal of Infectious Diseases. 165(4). 757–760. 19 indexed citations
13.
Yang, Jinshui, Min Luo, Yunzhu Wang, et al.. (1991). Introduction of Foreign Gene into Small Cell Groups Digested Partial-Enzymically in Rice and Regeneration of Transgenic Plants. Journal of Integrative Plant Biology. 33(11). 1 indexed citations
14.
Testa, Douglas, et al.. (1990). Detection of picogram amounts of nucleic acid by dot blot hybridization.. PubMed. 8(6). 628–32. 11 indexed citations
15.
Lee, Nancy, et al.. (1988). A rapid multicolor Western blot. Journal of Immunological Methods. 106(1). 27–30. 14 indexed citations
16.
Lee, Nancy, Jinshui Yang, & Douglas Testa. (1988). A simplified high speed multicolor immunoblotting method. Analytical Biochemistry. 175(1). 30–34. 11 indexed citations
18.
Testa, Douglas, et al.. (1980). In vitro synthesis of the full-length complement of the negative-strand genome RNA of vesicular stomatitis virus.. Proceedings of the National Academy of Sciences. 77(1). 294–298. 36 indexed citations
19.
Testa, Douglas, et al.. (1980). Unique mode of transcription in vitro by vesicular stomatitis virus. Cell. 21(1). 267–275. 88 indexed citations
20.
Testa, Douglas & A K Banerjee. (1979). Nucleoside diphosphate kinase activity in purified cores of vesicular stomatitis virus.. Journal of Biological Chemistry. 254(18). 9075–9079. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026